Association Between PM2.5 Exposure and Ferroptosis in Seizures Patients

Sponsor
Affiliated Hospital of Jiangnan University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05758129
Collaborator
(none)
60
1
3.7
16

Study Details

Study Description

Brief Summary

This cohort study aims to discover the possible effects of PM2.5 exposures on the Nrf2- dependent ferroptosis pathway in seizure patients. This observational cohort's main question is whether PM2.5 exposures will affect the Nrf2- dependent ferroptosis pathway in seizure patients.

Participants will be divided into two groups: the control group and the air pollution to detect the biomarkers of the Nrf2- dependent ferroptosis pathway in seizure patients

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Background: Despite the exact mechanism of the effects of air pollution (PM2.5) on the central nervous system is still under debate. There is increasing evidence that air pollution (PM2.5) will affect neurodegenerative diseases including epilepsy. It is well known that air pollution (PM2.5) will increase the level of proinflammatory cytokine released by microglia, and advanced research indicated the level of interleukin-6 will affect epilepsy symptoms. In addition, our previous research indicated that Nrf2 plays a crucial role in seizure symptoms and cognitive function (NCT05269901). However, whether PM2.5-induced proinflammatory cytokine released by microglia will change Nrf2- dependent ferroptosis to facilitate seizure symptoms and cognitive function is still unexplored. Therefore, this pilot cohort study aims to discover the potential association between PM2.5 exposures and the changes in the interleukin-6 level and Nrf2- dependent ferroptosis pathway

    Methods:
    1. The investigators first enrolled 30 low PM2.5 exposure epileptic children and aged-matched high PM2.5 exposure children who were recently diagnosed with epilepsy (< 2 months)from two cities (Yangzhou and Xuzhou) as the control and air pollution group based on previous PM2.5 records;

    2. Recorded the PM2.5 level in two cities every 5 days between 2022.12 and 2023.3 to compare the difference;

    3. Interleukin-6 ELISA(IL6) KIT was used to compare the proinflammatory cytokine level in two groups

    4. 4 Hydroxynonenal (4HNE) ELISA KIT was used to compare the lipid reactive oxygen species level in two groups

    5. Real-Time Quantitative PCR(RT-qPCR) was used to compare messenger RNA (mRNA) expression of the Nrf2-dependent ferroptosis pathway (Nrf2, SLC7A11, GPX4) Detailed Methods protocol

    6. PM2.5 level source: the PM2.5 levels were recorded via the data from the Ministry of Ecology and Environment of the People's Republic of China (air.cnemc.cn:18007/) 2. Sample collection: At the end of this study, the enrolled participant will come to the hospital to collect peripheral Blood (Affiliated Hospital of Jiangnan University and Xuzhou Children's Hospital, respectively), and the blood samples were collected into ethylene diamine tetraacetic acid(EDTA) vacutainer tubes and then divided into leukocytes and plasma for further experiments 3. Interleukin-6 and 4HNE: Plasma IL-6 and 4HNE concentrations were detected by the competitive ELISA method 4. RTqPCR sequence: h-GPX4 forward: 5'-GAGGCAAGACCGAAGTAAACTAC-3' h-GPX4 reverse: 5'-CCGAACTGGTTACACGGGAA-3' h-SLC7A11 forward: 5'-TCTCCAAAGGAGGTTACCTGC-3' h-SLC7A11 reverse: 5'-AGACTCCCCTCAGTAAAGTGAC-3' h-Nrf2 forward5'-ATAGCTGAGCCCAGTATC-3' h-Nrf2 reverse 5'- CATGCACGTGAGTGCTCT-3' h-GAPDH forward: 5'-GGAGCGAGATCCCTCCAAAAT-3' h-GAPDH reverse: 5'-GGCTGTTGTCATACTTCTCATGG-3'

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    60 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Association Between PM2.5 Exposure and Nrf2-depended Ferroptosis Changes in Seizures Patients
    Actual Study Start Date :
    Dec 1, 2022
    Anticipated Primary Completion Date :
    Mar 10, 2023
    Anticipated Study Completion Date :
    Mar 25, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    The control group

    the invited recently diagnosed with epilepsy (< 2 months) live in Wuxi, Jiangsu, China (low PM2.5 level based on previous official PM2.5 records)

    The PM2.5 exposure group

    the invited recently diagnosed with epilepsy live in Xuzhou, Jiangsu, China (high PM2.5 level based on previous official PM2.5 records)

    Outcome Measures

    Primary Outcome Measures

    1. The level changes of baseline IL6 three months later [From the date of all participants documented baseline data, until the date of the last participant documented the changes of biomarkers in peripheral blood, assessed up to 90 days]

      Biomarkers of proinflammatory cytokine

    2. The level changes of baseline 4HNE three months later [From the date of all participants documented baseline data, until the date of the last participant documented the changes of biomarkers in peripheral blood, assessed up to 90 days]

      Biomarkers of ferroptosis, an indicator of lipid reactive oxygen species

    3. The level changes of baseline of mRNA expression of the Nrf2-dependent ferroptosis three months later [From the date of all participants documented baseline data, until the date of the last participant documented the changes of biomarkers in peripheral blood, assessed up to 90 days]

      Biomarkers of the Nrf2- dependent ferroptosis

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Recently diagnosed with epilepsy (< 2 months)

    2. living in this city for more than two years

    3. no exposure to any chemistry pollution before

    Exclusion Criteria:
    1. abnormal IL-6 level before starting this pilot cohort

    2. other neurological disorders except for epilepsy;

    3. endocrine diseases;

    4. cancer

    5. receive anti-proinflammatory cytokines therapy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Affiliated Hospital of JiangNan University, Department of Pediatrics Wuxi Jiangsu China 226600

    Sponsors and Collaborators

    • Affiliated Hospital of Jiangnan University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Affiliated Hospital of Jiangnan University
    ClinicalTrials.gov Identifier:
    NCT05758129
    Other Study ID Numbers:
    • 2022/11/16
    First Posted:
    Mar 7, 2023
    Last Update Posted:
    Mar 7, 2023
    Last Verified:
    Feb 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Affiliated Hospital of Jiangnan University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 7, 2023